Irvine CA 卵巢癌临床试验
12项针对 卵巢癌的研究正在 Irvine及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
招募中2/3 期
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
招募中1/2 期
- Research Site, Irvine
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
招募中1 期
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 280914, Irvine
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
招募中1/2 期
- The City of Hope Orange County Lennar Foundation Cancer Center, Irvine
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
招募中3 期
- City of Hope Lennar, Irvine
- Kaiser Permanente Zion Medical Center, Irvine
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
招募中1/2 期
- City of Hope, Irvine, Irvine
A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
招募中
- City of Hope at Irvine Lennar, Irvine
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
招募中
- City of Hope at Irvine Lennar, Irvine
- Kaiser Permanente-Irvine, Irvine
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
招募中3 期
- Kaiser Permanente-Irvine, Irvine
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
招募中2 期
- City of Hope Lennar, Irvine
CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer
招募中1/2 期
- City of Hope, Irvine
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Irvine
其他城市的 卵巢癌试验
- Houston, TX89 项研究
- New York City, NY69 项研究
- Boston, MA61 项研究
- Los Angeles, CA50 项研究
- Nashville, TN49 项研究
- Arlington, VA46 项研究
- Philadelphia, PA44 项研究
- Columbus, OH39 项研究
- St. Louis, MO38 项研究
- Chicago, IL36 项研究
- San Antonio, TX31 项研究
- Cleveland, OH30 项研究
Irvine的其他研究
- 非小细胞肺癌25 项研究
- 乳腺癌23 项研究
- 癌症（所有类型）17 项研究
- 转移性癌症16 项研究
- 肺癌15 项研究
- 多发性骨髓瘤14 项研究
- 前列腺癌14 项研究
- 头颈鳞状细胞癌11 项研究
- 膀胱癌11 项研究
- 阿尔茨海默病11 项研究
- 结直肠癌10 项研究
- 胰腺癌10 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。